Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Hadron Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.6% during the forecast period.
This report presents the market size and development trends by detailing the Hadron Therapy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Hadron Therapy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Hadron Therapy industry and will help you to build a panoramic view of the industrial development.
Hadron Therapy Market, By Type:
Electron Beam
Proton Beam
Neutron Beam
Carbon Ion Beam
Alpha Particle Beam
Beta Particle Beam
Hadron Therapy Market, By Application:
Pediatric Cancer
Bone and Soft Tissue Cancer
Prostate Cancer
Lung Cancer
Liver Cancer
Eye Cancer
Head & Neck Cancer
Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
Some of the leading players are as follows:
Sumitomo Corporation.
Mevion Medical Systems
ProTom International
Mitsubishi Electric Corporation
Hitachi, Ltd.
Koninklijke Philips N.V.
Koninklijke Philips NV.
ProNova Solutions, LLC
Advanced Oncotherapy
Optivus Proton Therapy, Inc
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Hadron Therapy Market: Technology Type Analysis
-
4.1 Hadron Therapy Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Hadron Therapy Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Electron Beam
4.3.2 Proton Beam
4.3.3 Neutron Beam
4.3.4 Carbon Ion Beam
4.3.5 Alpha Particle Beam
4.3.6 Beta Particle Beam
5 Hadron Therapy Market: Product Analysis
-
5.1 Hadron Therapy Product Market Share Analysis, 2018 & 2026
-
5.2 Hadron Therapy Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Hadron Therapy Market: Application Analysis
-
6.1 Hadron Therapy Application Market Share Analysis, 2018 & 2026
-
6.2 Hadron Therapy Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Pediatric Cancer
6.3.2 Bone and Soft Tissue Cancer
6.3.3 Prostate Cancer
6.3.4 Lung Cancer
6.3.5 Liver Cancer
6.3.6 Eye Cancer
6.3.7 Head & Neck Cancer
6.3.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
7 Hadron Therapy Market: Regional Analysis
-
7.1 Hadron Therapy Regional Market Share Analysis, 2018 & 2026
-
7.2 Hadron Therapy Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sumitomo Corporation.
9.1.1 Sumitomo Corporation. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Mevion Medical Systems
9.2.1 Mevion Medical Systems Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 ProTom International
9.3.1 ProTom International Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Mitsubishi Electric Corporation
9.4.1 Mitsubishi Electric Corporation Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Hitachi, Ltd.
9.5.1 Hitachi, Ltd. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Koninklijke Philips N.V.
9.6.1 Koninklijke Philips N.V. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Koninklijke Philips NV.
9.7.1 Koninklijke Philips NV. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 ProNova Solutions, LLC
9.8.1 ProNova Solutions, LLC Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Advanced Oncotherapy
9.9.1 Advanced Oncotherapy Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Optivus Proton Therapy, Inc
9.10.1 Optivus Proton Therapy, Inc Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 71 Figures and 120 Tables)
Figure Electron Beam Hadron Therapy market, 2015 - 2026 (USD Million)
Figure Proton Beam Hadron Therapy market, 2015 - 2026 (USD Million)
Figure Neutron Beam Hadron Therapy market, 2015 - 2026 (USD Million)
Figure Carbon Ion Beam Hadron Therapy market, 2015 - 2026 (USD Million)
Figure Alpha Particle Beam Hadron Therapy market, 2015 - 2026 (USD Million)
Figure Beta Particle Beam Hadron Therapy market, 2015 - 2026 (USD Million)
Figure Pediatric Cancer market, 2015 - 2026 (USD Million)
Figure Bone and Soft Tissue Cancer market, 2015 - 2026 (USD Million)
Figure Prostate Cancer market, 2015 - 2026 (USD Million)
Figure Lung Cancer market, 2015 - 2026 (USD Million)
Figure Liver Cancer market, 2015 - 2026 (USD Million)
Figure Eye Cancer market, 2015 - 2026 (USD Million)
Figure Head & Neck Cancer market, 2015 - 2026 (USD Million)
Figure Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Hadron Therapy market, by country, 2015 - 2026 (USD Million)
-
Table North America Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table North America Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table North America Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Canada Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Canada Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Europe Hadron Therapy market, by country, 2015 - 2026 (USD Million)
-
Table Europe Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Europe Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Europe Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Germany Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Germany Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table France Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table France Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Italy Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Italy Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Spain Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Spain Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hadron Therapy market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table China Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table China Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Japan Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Japan Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table India Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table India Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Hadron Therapy market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table MEA Hadron Therapy market, by country, 2015 - 2026 (USD Million)
-
Table MEA Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table MEA Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table MEA Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Hadron Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Hadron Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Hadron Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sumitomo Corporation. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mevion Medical Systems Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ProTom International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mitsubishi Electric Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hitachi, Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Koninklijke Philips N.V. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Koninklijke Philips NV. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ProNova Solutions, LLC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Advanced Oncotherapy Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Optivus Proton Therapy, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
